/
Pharmaceutical preparations company · DE · FY ends Dec · Revenue $24K · -4166.29% margin · -$503K FCF
The business is unprofitable at the operating level (-5701.79% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue grew 44.3%, still solid. Margins contracted 949.3pp, which offsets some of the top-line progress.
Negative free cash flow of -$534K. The business is consuming cash, not generating it. Operating margin contracted 949.3pp YoY, cost discipline may be slipping.
Profitability & Returns
Revenue (TTM)
$24K
▲ +44.3% YoY
Net Income (TTM)
-$1M
▼ -73.3% YoY
Op. Margin
-4166.29%
▼ -949.3pp YoY
ROIC
—
Cash Flow & Balance Sheet
FCF (TTM)
-$503K
▼ -114.0% YoY
Op. Cash Flow (TTM)
-$503K
▼ -106.8% YoY
Net Debt
-$74K
Net Cash Position
Cash & Equiv.
$74K
5Y CAGR: +2.3%
Continue Research